The performance of omentin-1 and irisin as a combined tool in diagnostic tests for both diseases in 1 patient was better than when used alone, indicating omentin-1 and irisin may have dual implications in metabolic disorder with a bidirectional association. The gene discussed is FNDC5; the disease is metabolic disease.